AdiMap vs Epicrispr Biotechnologies
AdiMap vs Epicrispr Biotechnologies, compared side by side on 20 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: AdiMap is on 56/100 and Epicrispr Biotechnologies on 62/100.
Where each one leads
AdiMap
- headcount: 139 against 51
- funding raised: $438M against $90.0M
Epicrispr Biotechnologies
- our overall score: 62/100 against 56/100
At a glance
| Measure | AdiMap | Epicrispr Biotechnologies |
|---|---|---|
| What it is | Biotechnology company specializing in antibody discovery and protein engineering for therapeutic applications. | Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD). |
| Category | Fintech, Trading, Intelligence, Data Science | Biotechnology, Therapeutics, Rare Diseases, Epigenetics |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Platform |
| Founded | 2010 | 2020 |
| Headquarters | Lebanon, United States | South San Francisco, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | AdiMap | Epicrispr Biotechnologies |
|---|---|---|
| Employees | 139 | 51 |
| Total funding | $438M | $90.0M |
| Latest round | Series D | Series C |
| Valuation | $3.7B | Not published |
| LinkedIn followers | 8,546 | 7,025 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | AdiMap | Epicrispr Biotechnologies |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 56/100 | 62/100 |
| Traction | 60/100 | 57/100 |
| Team | Not published | 40/100 |
| Search visibility | 29/100 | 20/100 |
| Quality | 70/100 | 78/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (40/100) | F (39/100) |
| Domain ratingLink authority, 0-100 | 40/100 | 40/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | AdiMap | Epicrispr Biotechnologies |
|---|---|---|
| Hosting | AWS | Not detected |
| CDN | Not detected | Cloudflare |
| CMS | WordPress | WordPress |
| Frameworks | Jquery, Bootstrap | Jquery, Tailwind CSS, Bootstrap |
| Analytics | Google Tag Manager, Linkedin Insight | Google Analytics 4 |
| Support stack | HubSpot | Not detected |
AdiMap vs Epicrispr Biotechnologies: common questions
Which is better, AdiMap or Epicrispr Biotechnologies?
On our 0-100 score Epicrispr Biotechnologies rates higher (62/100 against 56/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 20 data points above: read the rows that match what you are buying for.
How do AdiMap and Epicrispr Biotechnologies compare on the numbers?
AdiMap leads on headcount (139 against 51), funding raised ($438M against $90.0M). Epicrispr Biotechnologies leads on our overall score (62/100 against 56/100).
Read the full AdiMap review and pricing or the Epicrispr Biotechnologies review and pricing. You can also browse other AdiMap alternatives we track.